ArticleJournal of virology2025

A tissue-targeted prime/pull/keep therapeutic herpes simplex virus vaccine protects against recurrent ocular herpes infection and disease in HLA-A*0201 transgenic rabbits.

Aziz A Chentoufi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.